Skip to main content
SpringerLink
Log in

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

4 Klassifikations- und Diagnosekriterien

German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew’s disease and early forms

4 Classification and diagnostic criteria

  • Leitlinien
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Notes

  1. Eine Zulassung für symptomatische Patienten mit nr-axSpA bei objektivem Entzündungsnachweis besteht jetzt auch für Certolizumab. Die dieser Zulassung zugrunde liegender Studie konnte nicht in die systematische Literatursuche aufgenommen werden, da sie nach dem 31.07.2012 publiziert wurde: Landewé R, et al. (2014) Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomized placebo-controlled Phase 3 study. Ann Rheum Dis 73:39–47.

Literatur

  1. Dougados M et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34(10):1218–1227

    Article  CAS  PubMed  Google Scholar 

  2. Amor B, Dougados M, Mijiyawa M (1990) Criteria of the classification of spondylarthropathies. Rev Rhum Mal Osteoartic 57(2):85–89

    CAS  PubMed  Google Scholar 

  3. Rudwaleit M et al (2009) The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68(6):777–783

    Article  CAS  PubMed  Google Scholar 

  4. Rudwaleit M et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31

    Article  CAS  PubMed  Google Scholar 

  5. Versorgungsleitlinien, P.f.N. Nationale Versorgungsleitlinie Kreuzschmerz. AWMF Leitlinien 2010 05 November 2013 31.July 2012]

  6. Aydin SZ et al (2012) Validation of the ASAS criteria and definition of a positive MRI of the sacroiliac joint in an inception cohort of axial spondyloarthritis followed up for 8 years. Ann Rheum Dis 71(1):56–60

    Article  PubMed  Google Scholar 

  7. Linden S van der, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. U. Kiltz, M. Rudwaleit, J. Sieper und J. Braun geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren. This article is part of a supplement sponsored by AbbVie, Pfizer und UCB.

Author information

Authors and Affiliations

  1. Deutsche Gesellschaft für Rheumatologie (DGRh), -, -

    U. Kiltz, M. Rudwaleit, J. Sieper & J. Braun

Authors
  1. U. Kiltz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Rudwaleit
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Sieper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Kiltz.

Additional information

Die Empfehlung findet sich in Tab. 2.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiltz, U., Rudwaleit, M., Sieper, J. et al. DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen. Z. Rheumatol. 73 (Suppl 2), 40–43 (2014). https://doi.org/10.1007/s00393-014-1429-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-014-1429-5

Search

Navigation